期刊
JAPANESE JOURNAL OF CLINICAL ONCOLOGY
卷 42, 期 4, 页码 264-269出版社
OXFORD UNIV PRESS
DOI: 10.1093/jjco/hys007
关键词
brain metastases; re-irradiation; whole-brain irradiation
类别
资金
- Grants-in-Aid for Scientific Research [23591851, 22591390] Funding Source: KAKEN
To determine whether second whole-brain irradiation is beneficial for patients previously treated with whole-brain irradiation. A retrospective analysis was done for 31 patients with brain metastases who had undergone re-irradiation. Initial whole-brain irradiation was performed with 30 Gy/10 fractions for 87 of these patients. Whole-brain re-irradiation was performed with 30 Gy/10 fractions for 42 of these patients (340 Gy/120 fractions). Three patients underwent a third whole-brain irradiation. The median interval between the initial irradiation and re-irradiation was 10 months (range: 269 months). The median survival time after re-irradiation was 4 months (range: 121 months). The symptomatic improvement rate after re-irradiation was 68, and the partial and complete tumor response rate was 55. Fifty-two percent of the patients developed Grade 1 acute reactions. On magnetic resonance imaging, brain atrophy was observed in 36 of these patients after the initial irradiation and 74 after re-irradiation. Grade epsilon 2 encephalopathy or cognitive disturbance was observed in 10 patients (32) after re-irradiation. Based on univariate analysis, significant factors related to survival after re-irradiation were the location of the primary cancer (P 0.003) and the Karnofsky performance status at the time of re-irradiation (P 0.008). A Karnofsky performance status epsilon 70 was significant based on multivariate analysis (P 0.050). Whole-brain re-irradiation for brain metastases placed only a slight burden on patients and was effective for symptomatic improvement. However, their remaining survival time was limited and the incidence of cognitive disturbance was rather high.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据